Company performance
Current Price
as of Feb 07, 2025$18.50
P/E Ratio
32.77
Market Cap
$11.53B
Description
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Metrics
Overview
- HQKobe, HY
- SectorHealth Technology
- IndustryMedical Specialties
- Ticker6869
- Price$18.496859-0.79%
Trading Information
- Market cap$11.53B
- Float71.02%
- Average Daily Volume (1m)932,110
- Average Daily Volume (3m)1,181,105
- EPS$85.66
Company
- Revenue$491.29B
- Rev growth (1yr)11.24%
- Net income$14.97B
- Gross margin54.59%
- EBITDA margin27.90%
- EBITDA$36.42B
- EV$1.73T
- EV/Revenue3.52
- P/E32.77
- P/S3.56
- P/B3.97
- Debt/Equity12.63